Abstract
This Health Industry Insights report provides an overview of current IT
outsourcing trends in the commercial (sales, marketing, manufacturing, supply
chain) pharmaceutical market. Questions answered within this document include:
- How significant of a role does IT outsourcing play in the commercial pharmaceutical market?
- How large is the IT outsourcing market, and how quickly is it growing?
- What are the primary reasons pharmas outsource IT?
- Which IT areas in sales, marketing, manufacturing, and supply chain are currently being outsourced, and which are poised for growth?
- What are the most vital decision criteria pharmas use to choose outsourcing providers?
Eric Newmark, a senior research analyst with Health Industry Insights, believes
that " Pressure for life science companies to reduce costs has risen
significantly over the last five years. The industry has been hit by a double
edge sword, as drug patents expire and product pipelines need bolstering, and
generic companies continue to encroach on branded pharmaceutical companies'
market share. These issues, coupled with a sense of urgency to protect gross
margins, have driven pharmaceutical companies to examine IT outsourcing and
offshoring with increased interest. During 2008, 22.5% of life science
companies plan to increase IT outsourcing and we expect the market to continue
experiencing health growth for the next 2 to 3 years."
View Cart
